Baoguang Hu

Binzhou Medical University

Papers

1

Total Citations

4

H-Index

1

About

Baoguang Hu is a leading surgical oncologist whose research focuses on optimizing perioperative care for gastric cancer patients, particularly those undergoing advanced minimally invasive procedures after neoadjuvant chemotherapy. His major contribution lies in investigating the role of probiotic supplementation in enhancing short-term clinical outcomes following laparoscopic or robotic radical gastrectomy. By designing rigorous multicenter randomized controlled trials, Hu addresses critical gaps in postoperative recovery, including the management of gut microbiota disruption caused by chemotherapy and surgery. His work on the GISSG2023-01 study protocol, which has already garnered early citations, demonstrates his commitment to evidence-based improvements in surgical oncology. Hu’s research bridges oncology, nutrition, and surgical technique, offering potential to reduce complications and accelerate recovery in high-risk patients. With a growing citation impact, his studies are shaping clinical protocols for gastric cancer treatment. Hu’s dedication to advancing surgical outcomes through innovative perioperative strategies marks him as a rising authority in gastrointestinal oncology, particularly in the integration of probiotics into cancer care pathways.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Effect of perioperative probiotic supplements on the short-term clinical outcomes of patients undergoing laparoscopic or robotic radical gastrectomy after neoadjuvant chemotherapy: Study protocol for a multicenter randomized controlled trial (GISSG2023 - 01 Study)
4 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 25
🏛 Institutions: Binzhou Medical University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago